These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8776338)

  • 1. Adjuvant treatment with tamoxifen. Informed consent and follow up in aTTom trial are inadequate.
    Cunningham H
    BMJ; 1996 Aug; 313(7055):494. PubMed ID: 8776338
    [No Abstract]   [Full Text] [Related]  

  • 2. The optimal duration of adjuvant tamoxifen treatment for breast cancer remains uncertain: randomize into aTTom.
    Earl H; Gray R; Kerr D; Lee M
    Clin Oncol (R Coll Radiol); 1997; 9(3):141-3. PubMed ID: 9269542
    [No Abstract]   [Full Text] [Related]  

  • 3. Tamoxifen beyond 5 years--patients' decisions regarding entry to the aTTom trial.
    Ferguson MJ; Dewar JA
    Eur J Cancer; 2002 Sep; 38(14):1857-9. PubMed ID: 12204667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aromatase inhibitors in adjuvant therapy of breast cancer: before, instead of, or beyond tamoxifen.
    Pritchard KI
    J Clin Oncol; 2005 Aug; 23(22):4850-2. PubMed ID: 16009956
    [No Abstract]   [Full Text] [Related]  

  • 5. Tamoxifen and contralateral breast cancer.
    O'Regan R; Jordan VC; Gradishar WJ
    J Am Coll Surg; 1999 Jun; 188(6):678-83. PubMed ID: 10359362
    [No Abstract]   [Full Text] [Related]  

  • 6. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.
    Sharma R; Hamilton A; Beith J
    Cochrane Database Syst Rev; 2008 Oct; (4):CD004562. PubMed ID: 18843661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re: Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17.
    Vakaet L
    J Natl Cancer Inst; 2006 Aug; 98(16):1162; author reply 1162-3. PubMed ID: 16912269
    [No Abstract]   [Full Text] [Related]  

  • 8. Twelve-year mortality results of a randomized trial of 2 versus 5 years of adjuvant tamoxifen for postmenopausal early-stage breast carcinoma patients (SITAM 01).
    Alliot C
    Cancer; 2006 Jul; 107(1):215; author reply 215-6. PubMed ID: 16691577
    [No Abstract]   [Full Text] [Related]  

  • 9. Tamoxifen for early breast cancer.
    Early Breast Cancer Trialists' Collaborative Group
    Cochrane Database Syst Rev; 2001; (1):CD000486. PubMed ID: 11279694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tamoxifen--"golden standard" in the treatment of patients with early breast cancer].
    Semiglazov VF; Kostetskaia TV
    Vopr Onkol; 2001; 47(1):108-12. PubMed ID: 11317528
    [No Abstract]   [Full Text] [Related]  

  • 11. Adjuvant aromatase inhibitor therapy for early breast cancer: A review of the most recent data.
    Grana G
    J Surg Oncol; 2006 Jun; 93(7):585-92. PubMed ID: 16705732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does c-erbB2/HER2 overexpression predict adjuvant tamoxifen failure in patients with early breast cancer?
    Hu JC; Mokbel K
    Eur J Surg Oncol; 2001 Jun; 27(4):335-7. PubMed ID: 11417974
    [No Abstract]   [Full Text] [Related]  

  • 13. Tamoxifen vs the aromatase inhibitors: news from San Antonio, 2001.
    Munster PN; Horton J
    Cancer Control; 2001; 8(6):478-9. PubMed ID: 11807416
    [No Abstract]   [Full Text] [Related]  

  • 14. Current concepts in the endocrine therapy of breast cancer: tamoxifen and aromatase inhibitors.
    Singh Ranger G
    J Clin Pharm Ther; 2005 Aug; 30(4):313-7. PubMed ID: 15985044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radiotherapy and tamoxifen facilitate breast-preserving treatment of ductal carcinoma in situ of the breast].
    Sautter-Bihl ML
    Strahlenther Onkol; 1999 Dec; 175(12):620-1. PubMed ID: 10633790
    [No Abstract]   [Full Text] [Related]  

  • 16. STAR trial reports.
    Eur J Cancer; 2006 Aug; 42(12):1694. PubMed ID: 16998956
    [No Abstract]   [Full Text] [Related]  

  • 17. Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer: methodologic issues.
    Winquist E; Bramwell V; Vandenberg T
    J Clin Oncol; 2002 Sep; 20(17):3748-9; author reply 3749-50. PubMed ID: 12202679
    [No Abstract]   [Full Text] [Related]  

  • 18. World's largest breast cancer treatment trial supports anastrozole use.
    Oncology (Williston Park); 2002 Jan; 16(1):63. PubMed ID: 11831610
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of aromatase inhibitors as adjuvant therapy for early breast cancer in postmenopausal women.
    Mouridsen HT; Robert NJ
    Eur J Cancer; 2005 Aug; 41(12):1678-89. PubMed ID: 16098456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant trials of toremifene vs tamoxifen: the European experience.
    Holli K
    Oncology (Williston Park); 1998 Mar; 12(3 Suppl 5):23-7. PubMed ID: 9556787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.